(Total Views: 298)
Posted On: 01/04/2021 6:40:47 AM
Post# of 22465
The market is huge, ih8aloss.
There are a lot more applicants for FDA EUA approval of their antigen test that we never heard of because their approval was delayed, but got European CE approval and are on France's list.
Also consider that an antigen test is designed to tell if the person has the virus near it's beginning, when it is most infectious. The results are valid for no more than 72 hours estimated. Repeat tests are needed, maybe twice a week for workers.
People who isolate don't need to be tested.
People attending work, events, mass transit, all can put others at risk and need to be tested. Prevention is the best policy.
There is a continuing need for antigen tests - accurate and inexpensive and quick results. Billions of tests per year will be needed.
One Billion Tests-
It would take a test manufacturer 100 days of continuously manufacturing 10 million tests per day to reach one billion tests. Higher volumes get lower prices - Triedandtested has such prices on its ordering page. Tests may eventually cost $5 or less for really high volume numbers.
If Innova makes 8 million tests per day, that's over 3 billion tests and between $10 and $15 billion dollars per year from just one product. Dollar amounts are hypothetical just for showing an example.
Post vaccine, antibody tests are needed periodically to ensure protection is still effective, and to signal when next booster is needed. That's a second product in the billions.
Huge market. Advantage is to companies with the best overall package of tests but need is so great there is room for others.
There are a lot more applicants for FDA EUA approval of their antigen test that we never heard of because their approval was delayed, but got European CE approval and are on France's list.
Also consider that an antigen test is designed to tell if the person has the virus near it's beginning, when it is most infectious. The results are valid for no more than 72 hours estimated. Repeat tests are needed, maybe twice a week for workers.
People who isolate don't need to be tested.
People attending work, events, mass transit, all can put others at risk and need to be tested. Prevention is the best policy.
There is a continuing need for antigen tests - accurate and inexpensive and quick results. Billions of tests per year will be needed.
One Billion Tests-
It would take a test manufacturer 100 days of continuously manufacturing 10 million tests per day to reach one billion tests. Higher volumes get lower prices - Triedandtested has such prices on its ordering page. Tests may eventually cost $5 or less for really high volume numbers.
If Innova makes 8 million tests per day, that's over 3 billion tests and between $10 and $15 billion dollars per year from just one product. Dollar amounts are hypothetical just for showing an example.
Post vaccine, antibody tests are needed periodically to ensure protection is still effective, and to signal when next booster is needed. That's a second product in the billions.
Huge market. Advantage is to companies with the best overall package of tests but need is so great there is room for others.
(0)
(0)
